In this episode, we unpack the surge in employer coverage for costly GLP-1 weight-loss drugs and the ripple effects on benefits design, fairness, and company budgets. We also explore how the food industry is racing to launch “GLP-1-friendly” products—and what this says about incentives, personal responsibility, and whether drugs are becoming the benefit instead of a tool.
Get the top 40+ AI Models for $20 at AI Box: https://aibox.ai
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
